Grifols SA (GRF)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

€

Buy

€

arrow-up€0.165 (+1.53%)

Prices updated at 19 Dec 2025, 16:44 CET
| Prices minimum 15 mins delay
|
Prices in EUR
Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.
FTSE EuroFirst 300
arrow-up0.43%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
€11.04 - €10.57
€13.70 - €7.32
1.42
6,554.64m
19.74
-
2,993,194
1.42
1,839,277.76
1.71
687.55m
ES0171996087
0.55
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.